secwatch.observer — SEC 8-K summary
======================================

Issuer:     LISATA THERAPEUTICS, INC. (LSTA)
CIK:        0000320017
Form:       8-K
Filed at:   2026-04-15T23:59:59+00:00
Accession:  0001140361-26-014775
Event type: m_and_a
Sentiment:  negative
Materiality: 0.85
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Lisata acquisition in limbo: Kuva Labs delays tender offer, seeks new financing
-------------------------------------------------------------------------------

- Kuva Labs has not yet commenced tender offer for Lisata; deadline extended from April 3 to April 13, 2026.
- Kuva seeking alternative financing on more favorable terms; will launch tender only after financing finalized.
- Lisata in discussions with Kuva regarding financing and timing; no assurance of commencement or deal completion.
- Potential termination of Merger Agreement if tender not commenced; risks include termination fees and litigation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/320017/000114036126014775/0001140361-26-014775-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/320017/000114036126014775/ef20070652_form8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-014775

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer